Börsipäev 21. märts
Log in or create an account to leave a comment
-
Eilne päev Ühendriikide aktsiaturgudel oli 5,8 miljardi vahetatud aktsiaga madalaima käibega käesoleval aastal ning S&P 500 indeks lõpetas kauplemissessiooni 0,2% miinuses. Nasdaqi indeks käis päevasiseselt ära uuel rekordil, kuid lõpetas päeva muutumatul tasemel. Tähelepanu keskpunktis olid eelkõige FOMC liikmed, kellest Evans ei välistanud käesoleval aastal nelja intressimäära tõstmist, Harker arvas, et inflatsioon võib kujuneda mõõdukalt kõrgemaks FEDi 2% eesmärgist ning Kashkari sõnul peaks keskpank asetama tulevikus rõhu bilansimahu vähendamisele.
Euroopas langes Stoxx 600 indeks 0,2%. Deutsche Bank teatas eile, et müüb investoritele €8 miljardi väärtuses uusi aktsiaid 35% madalama hinnaga kui eelmise nädala sulgemishind. Ettevõtte aktsia lõpetas päeva 3,7% miinuses.
Sarnaselt eilsega jääb makrokalender täna suhteliselt tühjaks. Avaldamisele tuleb UK veebruari tarbijahinnaindeksi muutus ning USA neljanda kvartali jooksevkonto seis.
11:30 UK tarbijahinnaindeks (veebruar)
12:00 Inglismaa keskpanga juhi Mark Carney kõne
12:00 FOMC liikme William Dudley kõne
14:30 USA jooksevkonto (Q4)
18:00 FOMC liikme Esther George’i kõne -
UK tarbijahinnaindeks kasvas veebruaris võrreldes aastatusega 2,3%, ületades analüütikute 2,1% suurust ootust. Tegu on kiireima hinnakasvuga alates 2013. aasta septembrist. Peamise panuse andis transpordi komponent seoses kütuse kallinemisega. Veebruariga lõppes ka kolm aastat kestnud toidukaupade hinnalangus, kui viimaste hinnad kerkisid 0,3%.
-
USA neljanda kvartali jooksevkonto puudujääk oli arvatust väiksem.
Q4 Current Account Balance -$112.4 bln vs -$128.2 bln Briefing.com consensus -
Gapping up
In reaction to strong earnings/guidance:
TENX +18.4%, CMCM +1.9%, FRAN +1.7%
Select EU financial related names showing strength:
BCS +3.3%, SAN +3.2%, ING +2.5%, BBVA +2.5%, LYG +1.7%, CS +1.6%, RBS +1.4%, PUK +1.1%, HSBC +1%
Select oil/gas related names showing strength:
WFT +2.1%, TNP +1.4%, STO +1.2%, TOT +1%, WLL +0.9%, RIG +0.8%, BP +0.7%, RDS.A +0.7%
Other news:
PTIE +48.5% (receives positive regulatory guidance from FDA for REMOXY)
HTBX +23.7% (announces the latest results of its ongoing Phase 2 clinical trial of HS-110 in combination with Opdivo for the treatment of non-small cell lung cancer)
CBK +13.3% (CEO Joel Waller discloses the purchase of 20k shares at $1.26)
WCST +0.9% (Enters into a Capital Increase Agreement with Guizhou Sun Seven Stars Technology Company Limited)
Analyst comments:
WMGI +2.7% (upgraded to Buy from Neutral at Northcoast)
FCX +2.4% (upgraded to Hold from Sell at Deutsche Bank)
CCL +1% (upgraded to Outperform from Market Perform at William Blair)
PAAS +0.9% (upgraded to Outperform at RBC Capital Mkts)
BWXT +0.9% (upgraded to Buy from Neutral at BofA/Merrill)
FB +0.7% (upgraded to Buy from Neutral at BTIG Research)
Gapping down
In reaction to disappointing earnings/guidance:
CSIQ -8.5%, LGL -5.4%, WTT -4.4%, GIS -2.1%, LEN -1.3%
M&A news:
ERIC -0.8% (ERIC Chairman in CNBC interview says he has never been involved in potential merger discussions with Cisco)
Other news:
DB -5.6% (Bloomberg reporting that the company may be fined by US authorities over Forex activities)
GEL -5.5% (prices offering of 4 mln common units for proceeds of $124 mln)
CALA -4.8% (Commences 4.5 mln common stock offering)
AKAO -3.9% (Chief Medical Officer Ian R. Friedland, M.D. to resign)
LJPC -3.7% (Commences $100 mln common stock offering)
RDY -3.6% (report suggesting regulatory concerns from the FDA)
GBDC -3.1% (To make a public offering of 1.75 mln shares of its common stock)
FSM -2.5% (Announces possible delay in filing its annual financial results)
KEYS -1.9% (Launches underwritten public offering of $400 mln of common shares)
Analyst comments:
SJM -1.5% (downgraded to Underperform at Bernstein)
MRUS -1.2% (downgraded to Neutral from Buy at Citigroup)
K -0.8% (downgraded to Underperform at Bernstein)
CPB -0.5% (downgraded to Underperform at Bernstein)
Briefing.com
